Literature DB >> 6532482

Factors affecting the reporting of symptoms by hypertensive patients.

M J Vandenburg, S J Evans, B J Kelly, F Bradshaw, W J Currie, W D Cooper.   

Abstract

Patients diagnosed as hypertensive have a high complaint rate, both on and off treatment and this has been postulated to be due to either their disease process, their being labelled as hypertensive, or to their treatment. Data from 6637 hypertensive patients being entered into clinical trials in general practice have been analysed to determine the relationship between the patient's age, sex, concurrent illnesses, concurrent medication, whether they were on antihypertensive treatment and the frequency of their reporting symptoms. The analysis was conducted using a multivariate technique. The frequency of reporting symptoms was greater in females than males. Those receiving antihypertensive therapy reported more symptoms than those who were not. This was notable with those receiving a beta-adrenoceptor blocker (47% of such patients complaining). Patients receiving concurrent medication were more likely to report a symptom than those not (48 compared to 37%). This was particularly noticeable if central nervous system-acting drugs were prescribed where the prevalence of symptoms was 52%. Patients already on antihypertensive treatment were more likely to be taking other medication for other conditions (37 vs 31%) than those not receiving antihypertensive treatment. Females were more likely to be taking other tablets than males (38 compared to 30%). The only symptoms which were less prevalent in those receiving treatment were headache, dizziness and breathlessness. All other symptoms were increased or unchanged in patients on antihypertensive therapy. This study indicates that present treatment for hypertension produces a high complaint rate from patients and that, when patients so complain, the possibility of their symptoms being due to their concurrent medication should be considered.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6532482      PMCID: PMC1463483          DOI: 10.1111/j.1365-2125.1984.tb02597.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Raynaud's phenomenon as side effect of beta-blockers in hypertension.

Authors:  A J Marshall; C J Roberts; D W Barritt
Journal:  Br Med J       Date:  1976-06-19

2.  A symptom questionnaire for hypertensive patients.

Authors:  C J Bulpitt; C T Dollery; S Carne
Journal:  J Chronic Dis       Date:  1974-08

3.  Symptoms and the discovery of high blood pressure.

Authors:  J O Robinson
Journal:  J Psychosom Res       Date:  1969-06       Impact factor: 3.006

4.  Hypertension and wellbeing.

Authors:  J S Gill; D G Beevers
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-19

5.  The influence of physicians' instructions on the outcome of antihypertensive therapy.

Authors:  W D Cooper; W J Currie; M J Vandenburg
Journal:  Br J Clin Pract       Date:  1983-03

6.  Adverse reactions to prescribed drugs in the elderly: a multicentre investigation.

Authors:  J Williamson; J M Chopin
Journal:  Age Ageing       Date:  1980-05       Impact factor: 10.668

7.  Tranquillizer use in middle-aged British men.

Authors:  R O Cummins; D G Cook; R C Hume; A G Shaper
Journal:  J R Coll Gen Pract       Date:  1982-12

8.  Information, compliance and side-effects: a study of patients on antidepressant medication.

Authors:  E D Myers; E J Calvert
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

9.  Treatment of hypertension with beta-adrenoceptor blocking drugs.

Authors:  T R Bai; D Webb; M Hamilton
Journal:  J R Coll Physicians Lond       Date:  1982-10
  9 in total
  6 in total

1.  Aspects of quality of life on treatment with felodipine.

Authors:  E Dimenäs; M A Wallander; K Svärdsudd; I Wiklund
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Evaluation of three methods of symptom reporting in a clinical trial of felodipine.

Authors:  M A Wallander; E Dimenäs; K Svärdsudd; I Wiklund
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy.

Authors:  C Dahlöf; E Dimenäs; B Olofsson
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

Review 4.  Systemic hypertension, headache, and ocular hemodynamics: a new hypothesis.

Authors:  Vinod Kumar Gupta
Journal:  MedGenMed       Date:  2006-09-12

5.  Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group.

Authors:  C Dahlöf; T Hedner; T Thulin; S Gustafsson; S O Olsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  A profile of adverse effects of antihypertensive medicines in a tertiary care clinic in Nigeria.

Authors:  Abimbola O Olowofela; Ambrose O Isah
Journal:  Ann Afr Med       Date:  2017 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.